Surface Oncology Inc.

NASDAQ: SURF · Real-Time Price · USD
1.07
-0.01 (-0.93%)
At close: Sep 07, 2023, 10:00 PM

Surface Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
50.91M 56.05M
Short-Term Investments
73.91M 98.1M
Long-Term Investments
n/a n/a
Other Long-Term Assets
1.6M 1.98M
Receivables
n/a n/a
Inventory
-197K -765K
Other Current Assets
4.32M 3.2M
Total Current Assets
129.14M 157.35M
Property-Plant & Equipment
29.17M 31.52M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
30.77M 33.5M
Total Assets
159.91M 190.85M
Account Payables
256K 1.55M
Deferred Revenue
n/a 9.85M
Short-Term Debt
5.79M 5.38M
Other Current Liabilities
10.21M 13.09M
Total Current Liabilities
16.26M 20.02M
Long-Term Debt
50.25M 51.92M
Other Long-Term Liabilities
n/a n/a
Total Long-Term Liabilities
50.25M 51.92M
Total Liabilities
66.51M 71.95M
Total Debt
56.04M 57.31M
Common Stock
6K 5K
Retained Earnings
-204.33M -140.74M
Comprehensive Income
-1.01M -221K
Shareholders Equity
93.4M 118.9M
Total Investments
73.91M 98.1M